Status:

COMPLETED

Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery

Lead Sponsor:

B. Braun Melsungen AG

Collaborating Sponsors:

B.Braun Taiwan Co., Ltd.

Conditions:

GI Cancer

Eligibility:

All Genders

18-80 years

Phase:

PHASE3

Brief Summary

Evaluation of the impact of peri- and post-operative parenteral nutrition enriched with n-3 PUFA on post-operative inflammatory processes.

Eligibility Criteria

Inclusion

  • Patients considered for major surgery for gastric and colorectal cancer
  • expected requirement for post operative PN or TPN of at least 7 days
  • possibility of PN/TPN provision 1 day prior to surgery
  • Age \>18 years old and \<80 years old
  • Hemodynamically stable
  • Written Informed consent

Exclusion

  • Participation in a clinical study with an investigational drug or an investigational medical device within one month prior to the start of study
  • Patients with sepsis, severe sepsis or septic shock
  • Known or suspected drug abuse
  • Intrahepatic cholestasis
  • General contraindications for infusion therapy such as acute pulmonary edema, hyperhydration and decompensated cardiac insufficiency
  • Pregnancy (positive in urine) or lactation
  • Autoimmune disease e.g. HIV
  • Known hypersensitivity to egg-, soy-, and fish proteins or any of the ingredients of the investigational products
  • Hemodynamic failure of any origin (hemorrhagic shock, myocardial infarction, cardiac failure)
  • Alterations of coagulation (thrombocytes \<150000 /mm3), PT \< 50%, PTT \> 40 sec
  • Ketoacidosis caused by Diabetes mellitus within 7 days prior to onset of study
  • Renal insufficiency with serum creatinine \> 1.4 mg/dL (\>124 µmol/L)
  • Patients with severe liver dysfunction with bilirubin \>2.5 mg/dL (\> 43 µmol/L)
  • Lipid disorders, in particular fasting serum triglycerides \> 250 mg/dL (\>2.85 mmol/L),

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2010

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00798447

Start Date

November 1 2008

End Date

October 1 2010

Last Update

June 9 2011

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kaohsiung Medical University Hospital

Kaohsiung City, Taiwan

2

National Taiwan University Hospital Taipei

Taipei, Taiwan

Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery | DecenTrialz